Skip to content
CIFAR header logo
fr
menu_mobile_logo_alt
  • Our Impact
    • Why CIFAR?
    • Impact Clusters
    • News
    • CIFAR Strategy
    • Nurturing a Resilient Earth
    • AI Impact
    • Donor Impact
    • CIFAR 40
  • Events
  • Programs
    • Research Programs
    • Pan-Canadian AI Strategy
    • Next Generation Initiatives
    • CIFAR Arrell Future of Food Initiative
  • People
    • Fellows & Advisors
    • CIFAR Azrieli Global Scholars
    • Canada CIFAR AI Chairs
    • AI Strategy Leadership
    • Leadership
    • Staff Directory
  • Support Us
  • About
    • Our Story
    • Awards
    • Partnerships
    • Publications & Reports
    • Careers
    • Equity, Diversity & Inclusion
    • Statement on Institutional Neutrality
    • Research Security
  • fr
News

Research team identifies human disease gene with the help of fruit flies

By: CIFAR
2 Apr, 2012
April 2, 2012
Banner GN

CIFAR Fellow Eric A. Shoubridge with his colleagues at McGill University collaborated with researchers at Baylor College of Medicine in Houston to discover a gene that causes neurodegeneration in fruit flies and a progressive neurodegenerative disease that leads to coordination problems in humans called Recessive Ataxia (ARSAL).

The gene produces a protein in the mitochondria – an organelle in the cell that produces the majority of a cell’s energy supply. Defects in genes like this are known to be associated with human metabolic and neurological diseases. By discovering that the gene caused neurodegeneration in fruit flies, the team was then able to use this knowledge to discover that ARSAL was caused by the same gene in humans. The group’s findings were published in PLoS Biology.

“This study underscores the increasingly recognized importance of mitochondrial dysfunction in neurological disorders,” explains Dr. Shoubridge. “It also illustrates the important role of model organisms in the discovery and characterization of neurological disease genes.”

In this study, researchers at Baylor College first found that fruit flies with degenerative neurons in their eyes also had defects in the gene Aats-met, which codes for a mitochondrial protein. The team’s finding was especially interesting because humans have their own version of the same gene, called MARS2. This sparked the question of whether defects in MARS2 also cause disease in humans.

With this in mind, the team at Baylor searched through previously published studies, to see if there were any human neurological disorders known to be caused by defects in the region of the genome where MARS2 is located. The team landed upon the published work from the group at McGill University, who discovered in 2006 that the human disease ARSAL was caused by defects in the region of DNA where MARS2 is found. However, the precise gene responsible for the disease was still a mystery.

The team at Baylor connected with the researchers at McGill, who were then able to use the new knowledge from the fruit fly and investigate the role of the human gene MARS2 in ARSAL. As Dr. Shoubridge explains, “the genetic defects in the ARSAL patients were particularly difficult to identify. The fact that research in the fruit fly identified MARS2 mutations encouraged my colleague Dr. Brais’ lab to persist in their analysis of this locus.” They discovered that ARSAL patients did have rearrangements of the MARS2 gene that impaired the function of mitochondria. Dr. Shoubridge’s lab played a role by investigating the effect of the gene rearrangements. His lab found that the rearrangements decreased the production of the MARS2 protein as well as other mitochondrial proteins. The patient cells also had similar abnormalities as fruit flies with mutations in their Aats-met gene.

This study demonstrates how colleagues working in distant labs can come together to collaborate and shed new light on important causes of human diseases. It also shows how we can strategically use fruit fly models to identify human disease genes, and potentially
identify treatment approaches in patients.

  • Follow Us

Related Articles

  • CIFAR welcomes new and renewed Canada CIFAR AI Chairs
    December 04, 2025
  • Building safer AI with advanced evaluation methods
    December 03, 2025
  • Jacobs CIFAR Research Fellowship supports next-gen research on childhood development and learning
    November 24, 2025
  • CIFAR launches new AI safety Networks to address synthetic evidence in the legal system and linguistic inequality
    November 19, 2025

Support Us

The Canadian Institute for Advanced Research (CIFAR) is a globally influential research organization proudly based in Canada. We mobilize the world’s most brilliant people across disciplines and at all career stages to advance transformative knowledge and solve humanity’s biggest problems, together. We are supported by the governments of Canada, Alberta and Québec, as well as Canadian and international foundations, individuals, corporations and partner organizations.

Donate Now
CIFAR header logo

MaRS Centre, West Tower
661 University Ave., Suite 505
Toronto, ON M5G 1M1 Canada

Contact Us
Media
Careers
Accessibility Policies
Supporters
Financial Reports
Subscribe

  • © Copyright 2025 CIFAR. All Rights Reserved.
  • Charitable Registration Number: 11921 9251 RR0001
  • Terms of Use
  • Privacy
  • Sitemap

Subscribe

Stay up to date on news & ideas from CIFAR.

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.
Accept Learn more